LLY directional thesis
The $51 billion blockbuster behind this trillion-dollar drugmaker loses 90 to 95% of its price the day it goes off patent, and generics eat the rest.
“So Lilly today is— Lilly today is a $1 trillion company, right? Or just about. But I think the issue really in biotech with gains of $100 trillion would be the patent cliff.”93:31claim_id
mcl_df086566372a6f0cf4open evidence ↗Human-reviewed public claim.
Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.
Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.